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Abstract	
Background	
Although	rheumatology	nursing	has	been	shown	to	be	effective	 in	managing	patients	with	
rheumatoid	arthritis,	patient	outcomes	sensitive	to	nursing	interventions	(nursing	sensitive	
outcomes)	have	not	been	systematically	studied.		
Objectives	
The	 objective	 of	 this	 study	 was	 to	 identify	 and	 delineate	 relevant	 patient	 outcomes	
measured	 in	 studies	 that	 reported	 nursing	 interventions	 in	 patients	 with	 rheumatoid	
arthritis.	
Design	
A	systematic	search	was	conducted	from	1990-2016.	Inclusion	criteria	were	(i)	patients	with	
rheumatoid	arthritis,	(ii)	adult	population	age	≥	16	years,	(iii)	nurse	as	part	of	the	care	team	
or	 intervention	 delivery,	 (iv)	 	 primary	 research	 only,	 (v)	 English	 language,	 and	 (vi)	
quantitative	studies	with	nursing	sensitive	outcomes.			
Data	sources	
Medline,	CINAHL,	Ovid	nursing,	Cochrane	library	and	PsycINFO	databases	were	searched	for	
relevant	studies.	
Review	methods	
Using	 the	 predetermined	 inclusion/exclusion	 criteria,	 nine	 reviewers	 working	 in	 pairs	
assessed	the	eligibility	of	the	identified	studies	based	on	titles	and	abstracts.	Papers	meeting	
the	 inclusion	criteria	were	retrieved	and	full	 texts	were	further	assessed.	Critical	Appraisal	
Skills	 Programme	 tools	 were	 used	 to	 assess	 the	 quality	 of	 the	 included	 studies.	 Data	 on	
nursing	sensitive	outcomes	were	extracted	independently	by	two	reviewers.	The	Outcome	
Measures	 in	 Rheumatology	 comprehensive	 conceptual	 framework	 for	 health	was	 used	 to	
contextualise	and	present	findings. 
Results	
Of	the	820	articles	retrieved,	7	randomised	controlled	trials	and	3	observational	studies	met	
the	 inclusion	 criteria.	 Seventeen	 nursing	 sensitive	 outcomes	 were	 identified	 (disease	
activity,	clinical	effects,	pain,	early	morning	stiffness	duration,	fatigue,	patient	safety	issues,	
function,	knowledge,	patient	satisfaction,	confidence	in	care	received,	mental	health	status,	
self-efficacy,	patient	attitude/perception	of	ability	to	control	arthritis,	quality	of	life,	health	
utility,	 health	 care	 resources,	 death).	 These	 fitted	 into	 10	 health	 intervention	 domains	 in	
keeping	 with	 the	 pre-specified	 conceptual	 framework	 for	 health:	 disease	 status,	
effectiveness,	safety,	function,	knowledge,	satisfaction,	psychological	status,	quality	of	 life,	
cost,	 death.	 A	 total	 of	 59	 measurement	 instruments	 were	 identified	 comprising	 patient	
reported	outcome	measures	(n=31),	and	biologic	measures	and	reports	(n=	28).	
Conclusions	
This	 review	 is	 notable	 in	 that	 it	 is	 the	 first	 to	 have	 identified,	 and	 reported,	 a	 set	 of	
multidimensional	 outcome	 measures	 that	 are	 sensitive	 to	 nursing	 interventions	 in	
rheumatology	specifically.	Further	research	is	required	to	determine	a	core	set	of	outcomes	
to	be	used	in	all	rheumatology	nursing	intervention	studies.	
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1. Introduction	
Rheumatoid	 arthritis	 is	 a	 chronic	 systemic	 inflammatory	 disease	 characterised	 by	
inflammation	of	multiple	 joints	and	may	 lead	to	severe	disability	and	premature	mortality	
(Gabriel	and	Michaud,	2009).	Pharmacological	management	targets	the	immune	system	and	
requires	vigilant	monitoring	by	health-care	professionals	and	patients.	Non-pharmacological	
interventions,	 such	 as	 exercise,	 joint	 protection,	 foot	 care	 and	 patient-education,	 aim	 to	
help	patients	manage	their	disease,	participate	in	social,	leisure	and	work-related	activities	
and	thus	optimise	their	health	(National	Collaborating	Centre	for	Chronic	Conditions,	2009,	
Zangi	et	al.,	2015).		
Rheumatology	 nursing	 is	 a	 practice	 specialty	which	 contributes	 significantly	 to	 the	
management	 of	 patients	 with	 rheumatoid	 arthritis	 (American	 Nurses	 Association	 and	
Rheumatology	 Nurses	 Society,	 2013,	 Carr	 A,	 2001,	 van	 Eijk-Hustings	 et	 al.,	 2012).	
Rheumatology	 nurses	 have	 many	 roles	 within	 the	 context	 of	 the	 multidisciplinary	 team	
ranging	 from	 disease	 management	 to	 coordination	 of	 the	 overall	 care	 for	 people	 with	
rheumatoid	arthritis	 (National	Collaborating	Centre	 for	Chronic	Conditions,	2009,	van	Eijk-
Hustings	et	al.,	2012).	Within	rheumatology	services,	nurse-led	care	continues	to	grow	as	a	
model	of	care	delivery	in	the	backdrop	of	the	global	shortage	of	rheumatologists,	increased	
need	for	patient	monitoring	in	the	out-patient	departments	and	the	increasing	standard	of	
education	 and	 experience	 of	 rheumatology	 nurses	 (Garner	 et	 al.,	 2017,	 Ryan,	 2017).	
Rheumatology	 nursing	 development	 follows	 a	 worldwide	 tendency	 among	 healthcare	
practitioners	 to	 provide	 a	 more	 proactive,	 evidence-based	 and	 patient-preference-based	
care	 (Laurant	M	et	 al.,	 2004,	 Loveman	et	 al.,	 2003,	Quill	 and	Holloway,	 2012).	 In	 2012,	 a	
European	 League	 against	 Rheumatism	 (EULAR)	 task	 force	 developed	 evidence-based	
recommendations	 for	 the	 role	 of	 the	 nurse	 in	 the	management	 of	 chronic	 inflammatory	
arthritis	 (van	 Eijk-Hustings	 et	 al.,	 2012).	 The	 recommendations	 were	 aimed	 to	 enhance	
standardisation	and	harmonisation	of	rheumatology	nursing	across	countries.		
While	 the	 evidence	 confirming	 that	 patient	 benefit	 from	 rheumatology	 nursing	
continues	 to	 grow,	 more	 high	 quality	 studies	 including	 international	 comparisons	 are	
required	to	further	strengthen	this	evidence	(van	Eijk-Hustings	et	al.,	2012).	However,	one	
of	 the	 critical	 challenges	 to	 evidence	 synthesis	 is	 lack	 of	 agreement	 on	 which	 outcome	
domains	 should	 be	 covered	 when	 evaluating	 rheumatology	 nursing	 care.	 Furthermore,	
methods	to	measure	outcomes	directly	related	to	nursing	interventions	are	limited	(Begley	
et	al.,	2010,	Gerrish,	2011).	This	hampers	comparability	of	studies	and	pooling	of	outcomes	
in	meta-analyses,	 and	 consequently	 limits	 clear	 and	 robust	 conclusions	 regarding	 nursing	
interventions	(Craig	et	al.,	2008,	Ndosi	et	al.,	2011).		
In	order	to	capture	the	valuable	and	unique	contribution	of	nursing	to	health	care,	it	
is	 important	 to	 identify	 outcomes	 that	 are	 sensitive	 to	 nursing	 (International	 Council	 of	
Nurses,	2009).	As	a	concept,	a	nursing	sensitive	outcome	can	be	defined	as	an	individual’s,	
family	or	community	state,	behaviour	or	perception	that	is	measured	along	a	continuum	in	
response	to	nursing	 intervention(s)	 (Moorhead	et	al.,	2013).	 In	 the	context	of	 this	study	a	
nursing	 sensitive	 outcome	 was	 defined	 as	 an	 individual’s	 area	 of	 health,	 behaviour	 or	
perception	 that	 responds	 to	 an	 intervention	 which	 includes	 nursing.	 Identifying	 patient	
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outcomes	in	rheumatology	that	are	sensitive	to	nursing	interventions	is	a	crucial	first	step	in	
the	development	of	a	core	outcome	set	for	use	in	this	context.		
An	 international	 initiative	 to	 improve	 outcome	 measurement	 in	 Rheumatology	
(OMERACT)	 developed	 a	 conceptual	 framework	 for	 health,	 and	 delineated	 a	 process	 for	
developing	core	outcome	sets,	collectively	termed	OMERACT	Filter	2.0	(Boers	et	al.,	2014).	
This	comprehensive	OMERACT	framework	(Figure	1)	is	designed	to	lead	to	the	development	
of	an	all-inclusive	core	set	of	outcome	measures	specific	to	the	context	for	which	this	core	
set	 is	 intended.	 	 This	 framework	 comprises	 two	 overarching	 concepts	 (Impact	 of	 health	
Conditions	and	Pathophysiological	Manifestations).	Impact	of	health	conditions	encompass	
three	 aspects	 of	 health	 (core	 areas);	 (i)	 death,	 (ii)	 life	 impact,	 (iii)	 resource	 use/economic	
impact.	Pathophysiological	manifestations	as	a	concept	is	not	further	subdivided	into	areas	
(Figure	1).	Each	core	area	is	subdivided	into	‘domains’,	defined	as	a	further	specification	of	
the	aspect	of	health	or	health	impact	to	be	measured.	In	all	studies,	domains	are	intended	
to	be	disease	and	context	specific.	As	a	next	step	in	the	development	of	core	outcome	sets,	
OMERACT	 recommends	 the	 identification	 of	 at	 least	 one	 valid,	 reliable	 and	 responsive	
measurement	 instrument	 to	measure	 each	 domain	 (Boers	 et	 al.,	 2014).	 This	 step	 usually	
requires	a	combination	of	literature	review	and	a	consensus	process.	
This	OMERACT	conceptual	framework	for	health	and	delineated	process	for	
development	of	core	set	outcomes	was	chosen	to	underpin	this	study.	With	a	long-term	
goal	of	developing	a	core	outcome	set	in	the	context	of	rheumatology	nursing,	an	
international	group	of	rheumatology	nurses	and	patient	research	partners	undertook	a	
systematic	review	to	delineate	all	outcomes	used	in	nursing	intervention	studies.	The	aim	of	
this	systematic	literature	review	therefore,	was	to	identify	nursing	sensitive	outcomes	and	
measurement	tools	that	have	been	used	to	date	in	studies	of	nursing	interventions	in	
patients	with	rheumatoid	arthritis.	
2. Methods	
2.0.		Design	
The	review	team	comprised	two	patient	research	partners	(from	Ireland	and	the	UK)	
and	 seven	 nurses	 and	 academics	 from	 Ireland,	 The	 Netherlands,	 the	 UK	 and	 the	 USA.	
Patient	 research	 partners	 are	 persons	 with	 a	 relevant	 disease	 who	 operate	 as	 active	
research	 team	 members	 on	 an	 equal	 basis	 with	 professional	 researchers,	 adding	 to	 the	
benefit	 of	 their	 experiential	 knowledge	 to	 a	 research	 project	 (de	 Wit	 et	 al.,	 2011).	 The	
patient	 research	 partners	 were	 all	 trained	 for	 and	 experienced	 in	 participating	 within	 all	
steps	of	the	OMERACT	research	process,	and	were	involved	in	the	study	from	its	inception.	
They	 participated	 as	 full	 researchers	 in	 the	 discussion	 about	 the	 necessity	 of	 this	 work;	
design	of	 the	 review;	study	selection	and	 in	 finalising	 the	manuscript.	A	 research	 librarian	
was	consulted	for	advice	on	search	terms	at	the	beginning	of	the	project	although	she	was	
not	part	of	the	research	team.	
The	 systematic	 review	 was	 guided	 by	 the	 Cochrane	 Collaborative	 methodology	
(Higgins	and	Green,	2009).	The	review	protocol	detailing	the	research	question,	objectives	
and	inclusion/exclusion	criteria	was	developed	and	agreed	upon	by	the	review	team	in	June	
2014	although	this	was	not	registered	or	published.			
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2.1.		Inclusion	Criteria	
Inclusion	 criteria	 were	 (i)	 patients	 with	 rheumatoid	 arthritis,	 in	 accordance	 with	
American	College	of	Rheumatology	classification	criteria	for	rheumatoid	arthritis	(Arnett	et	
al.,	1988)	and	the	American	College	of	Rheumatology/European	League	against	Rheumatism	
(ACR/EULAR)	 rheumatoid	 arthritis	 classification	 criteria	 (Aletaha	 et	 al.,	 2010),	 (ii)	 adult	
population	 age	 ≥	 16	 years	 (onset	 of	 arthritis	 prior	 to	 the	 age	 of	 16	 years	 is	 classified	 as	
juvenile	 idiopathic	arthritis	 (JIA),	as	distinct	 from	rheumatoid	arthritis	 (Petty	et	al.,	2004)),	
(iii)	rheumatology	nurse	as	part	of	the	care	team	or	intervention	delivery,	(iv)	dated	1990	–	
2016,	 (v)	 primary	 research	 only,	 (vi)	 English	 language,	 and	 (vii)	 quantitative	 studies	 with	
nursing	sensitive	outcomes.		
2.2.		Information	Sources	
A	 systematic	 literature	 search	 was	 executed	 in	 Medline,	 CINAHL,	 Ovid	 Nursing,	
Cochrane	 library	and	PsycINFO	 in	September	2014,	and	 the	search	was	updated	 in	March	
2016.		
2.3.		Search	
The	search	strategy	was	discussed	at	length	and	agreed	by	the	review	team.	Several	
preliminary	 searches	 were	 conducted	 to	 identify	 terms	 to	 encompass	 interventions	 and	
outcomes	 specific	 to	 rheumatology	 nursing.	 However,	 a	 large	 variation	 between	
descriptions	 of	 interventions	 and	 outcomes	 was	 found.	 On	 account	 of	 this	 diverse	
terminology,	to	ensure	capture	of	all	pertinent	papers,	it	was	agreed	to	undertake	broader	
search	terms	using	nurse	truncated	(nurs*)	only.	The	final	search	terms	used	in	all	databases	
were	“rheumatoid	arthritis”	(in	all	fields)	AND	“nurs*”	(in	title	or	abstract).		
2.4.		Study	selection	
The	 study	 selection	process	 comprised	7	 steps,	which	are	 summarised	 in	 Figure	2.	
Using	 EndNote®	 software	 results	 from	all	 database	 searches	were	merged	 and	duplicates	
were	 removed	 (steps	 1	 &	 2).	 For	 step	 3	 the	 review	 team	 sub-divided	 into	 four	 working	
groups,	minimum	two	 reviewers	per	group.	All	 abstracts	and	 titles	 that	 resulted	 from	 the	
search	were	 screened	 for	 eligibility	 using	 three	of	 the	 above	 inclusion	 criteria	 (adults	 age	
>16	 years	 at	 disease	 onset,	 nurse	 as	 part	 of	 care	 team	 or	 intervention	 delivery,	 primary	
research).	 Records	were	 retained	 if	 they	did	 not	 contain	 an	 abstract	 or	 if	 reviewers	were	
unable	 to	 ascertain	 if	 the	 above	 inclusion	 criteria	 applied.	 For	 step	 4	 the	 partners	 were	
rotated	between	working	groups	to	enhance	the	validity	in	re-screening	titles	and	abstracts.	
Only	 studies	 meeting	 the	 following	 criteria	 were	 retained:	 (i)	 quantitative	 studies	 with	
nursing	sensitive	outcomes	in	the	results	and	(ii)	English	language.	In	step	5,	full	texts	were	
obtained.	Papers	were	assessed	to	ensure	that	nursing	was	a	part	of	 the	 intervention	and	
reported	nursing	 sensitive	outcomes.	 In	 step	6,	 studies	with	mixed	diagnostic	 groups	 (i.e.	
rheumatoid	arthritis	and	psoriatic	arthritis)	and	 interventions	delivered	by	non-specialised	
rheumatology	nurses	 (for	example,	 generic	 smoking	cessations	programmes	not	delivered	
by	a	rheumatology	nurse),	were	excluded.	Step	7	was	an	update	of	the	literature	search.	
2.5.		Quality	Assessment		
Critical	 Appraisal	 Skills	 Programme	 tools	 (Cohort	 Checklist	 and	 Randomised	
Controlled	 Trial	 Checklist)	 were	 used	 to	 assess	 the	 quality	 of	 the	 included	 studies	 (CASP,	
2013).	Questions	1-6	relate	to	the	internal	validity	of	the	studies,	7-8	relate	to	validity	of	the	
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results	 and	 questions	 9-11	 relate	 to	 relevance	 to	 practice	 (external	 validity)	 of	 the	 study.	
Quality	 assessment	 was	 conducted	 independently	 by	 each	 group.	 Disagreements	 were	
resolved	by	discussion	either	between	the	group	partners	or	in	consultation	with	the	whole	
group.		
2.6.		Data	extraction	
For	 this	 study,	 a	 data	 extraction	 tool	 was	 devised	 to	 guide	 the	 extraction	 of	
information	 from	 the	 records	 in	 line	 with	 the	 study	 aim.	 The	 data	 extracted	 included:	
author,	title,	origin,	year,	type	of	patients,	age	of	patients,	study	design,	language,	if	nursing	
was	 part	 of	 intervention,	 outcomes	 and	 instruments	 and	 covariates	 (the	 template	 of	 the	
data	extraction	tool	can	be	found	 in	the	Supplementary	material	S1).	Data	were	extracted	
by	all	researchers	 independently	and	then	these	were	checked	between	pairs	and	later	by	
all	reviewers.	Subsequently,	the	following	data	were	also	extracted:	outline	of	intervention,	
methods	of	analysis,	results	related	to	effectiveness	of	the	interventions.		
2.7.		Synthesis	of	results	
Data	 synthesis	 was	 carried	 out	 qualitatively	 by	 one	 reviewer	 and	 subjected	 to	
rigorous	 discussion,	 cross	 checking	 and	 consensus	 by	 the	 research	 team.	 All	 nursing	
sensitive	 outcomes	 that	 were	 reported	 in	 the	 studies	 were	 delineated.	 Using	 a	 content	
analysis	approach,	context	specific	domains	for	this	study	were	identified	and	defined.	The	
nursing	 sensitive	 outcomes	 were	 categorised	 into	 these	 domains	 and	 subsequently	 were	
mapped	onto	the	OMERACT	core	areas	and	domains	(Table	1).	
3. Results	
3.0.		The	search	results	
Figure	 2	 presents	 the	 flow	 diagram	 of	 the	 systematic	 search.	 Of	 the	 820	 titles	
originally	 identified,	 115	 full	 texts	 were	 screened	 and	 eventually	 11	 papers	 reporting	 10	
studies	 (two	 papers	 (Hill	 et	 al.,	 1994	 and	 Hill,	 1997)	 reported	 results	 of	 one	 study)	were	
included	in	this	review.		
3.1.		Characteristics	of	the	included	studies	
An	 overview	 of	 the	 10	 studies	 summarising	 patient-related	 characteristics,	 the	
nursing	sensitive	outcomes,	the	associated	measurement	instruments	and	a	summary	of	key	
results	are	presented	in	Table	2.	The	10	included	studies	represented	7	RCTs	(Dougados	et	
al.,	2015,	Hill,	1997,	Hill	et	al.,	1994,	Hill	et	al.,	2003,	Ndosi	et	al.,	2014,	Primdahl	et	al.,	2014,	
Ryan	 et	 al.,	 2006,	 Tijhuis	 et	 al.,	 2003)	 and	 3	 observational	 studies	 comprised	 of	 2	 cohort	
studies	 (Maravic	 et	 al.,	 2000,	Watts	 et	 al.,	 2015)	 and	 1	 cross-sectional	 study	 (Arthur	 and	
Clifford,	 2004).	 The	majority	 (n=6)	 of	 the	 studies	 were	 conducted	 in	 the	 UK	 (Arthur	 and	
Clifford,	2004,	Hill	et	al.,	1994	and	Hill,	1997,	Hill	et	al.,	2003,	Ndosi	et	al.,	2014,	Ryan	et	al.,	
2006,	Watts	et	al.,	2015),	2	in	France	(Dougados	et	al.,	2015,	Maravic	et	al.,	2000),	and	one	
each	 in	Denmark	 (Primdahl	et	al.,	2014)	and	 in	The	Netherlands	 (Tijhuis	et	al.,	2003).	The	
purpose	of	all	studies	was	to	evaluate	patient	outcome.		
Seven	of	the	prospective	studies	assessed	the	effects	of	nurse-led	care	by	comparing	
patient	 outcomes	 following	 nurse-led	 care	 or	 usual	 (physician-led)	 care	 (Hill	 et	 al.,	 2003,	
Ndosi	et	al.,	2014,	Primdahl	et	al.,	2014,	Ryan	et	al.,	2006,	Watts	et	al.,	2015)	or	team	care	
(Tijhuis	 et	 al.,	 2003).	 The	 other	 two	 studies	 (Dougados	 et	 al.,	 2015,	Maravic	 et	 al.,	 2000)	
were	 slightly	different.	Dougados	et	 al	 (2015)	used	 two	active	 interventions	 to	 assess	 the	
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efficacy	 of	 nurse-led	 care	 in	 managing	 co-morbidities	 and	 patients’	 self-assessment	 of	
rheumatoid	arthritis	disease	activity.	Maravic	et	al.,	(2000)	was	not	a	comparative	study	but	
the	effects	of	 the	nursing	care	were	assessed	within	 the	context	of	multidisciplinary	care,	
with	 patient	 outcomes	 and	 costs	 followed	 prospectively	 for	 six	 months.	 The	 last	 study	
(Arthur	 and	 Clifford	 2004)	 was	 a	 cross-sectional	 study	 demonstrating	 the	 association	 of	
patient	satisfaction	with	care	provided	in	secondary	care	(rather	than	primary	care).		
3.2.		The	quality	assessment	
The	results	of	the	quality	assessment	of	the	included	studies	are	presented	in	Table	3	
(CASP,	2013).		All	randomised	controlled	trials	and	cohort	studies	were	of	a	good	quality,	on	
the	basis	that	they	had	a	positive	answer	to	at	 least	7	of	the	11	main	questions.	Only	1	of	
the	 randomised	 controlled	 trials	 satisfied	 all	 11	 questions	 of	 the	 CASP	 appraisal	 tool	
(Primdahl	et	al.,	2014),	3	satisfied	10	of	the	11	questions	(Dougados	et	al.,	2015,	Ndosi	et	al.,	
2011,	 Ryan	 et	 al.,	 2006),	 and	 the	 remaining	 two	 satisfied	 9	 and	 7	 of	 the	 11	 questions	
respectively	(Hill	et	al.,	1994	and	Hill,	1997;	Hill	et	al.,	2003).	For	the	3	cohort	studies	only	1	
study	(Watts	et	al.,	2015)	satisfied	all	11	appraisal	questions,	the	other	2	each	satisfied	9	of	
the	11	questions	(Arthur	and	Clifford	2004,	Maravic	et	al.,	2000).		
3.3.		Key	findings		
From	 the	 study	 summaries	 (Tables	 1-2)	 the	 nursing	 sensitive	 outcomes	 and	
measurements	instruments	were	identified	and	categorised	into	domains	and	mapped	onto	
the	 OMERACT	 Filter	 2.0	 four	 core	 areas	 (Table	 4)	 (Section	 2.7).	 In	 total,	 10	 domains	 for	
health	intervention	were	identified,	these	included:	(i)	disease	status,	(ii)	effectiveness,	(iii)	
safety,	(iv)	function,	(v)	knowledge,	(vi)	satisfaction,	(vii)	psychological	status,	(viii)	quality	of	
life,	 (ix)	 costs	 and	 (x)	 death.	 These	 domains	 were	 derived	 from	 the	 17	 nursing	 sensitive	
outcomes	 	 identified,	 including,	 (1)	 disease	 activity,	 (2)	 clinical	 effects,	 (3)	 pain,	 (4)	 early	
morning	 stiffness	 (EMS)	 duration,	 (5)	 fatigue,	 (6)	 patient	 safety	 issues,	 (7)	 function,	 (8)	
knowledge,	 (9)	 patient	 satisfaction,	 (10)	 confidence	 in	 care	 received,	 (11)	 mental	 health	
status,	(12)	self-efficacy,	(13)	patient	attitude/perception	of	ability	to	control	arthritis,	(14)	
quality	of	 life,	 (15)	health	utility,	 (16)	health	 care	 resources,	and	 (17)	death.	A	 total	of	59	
measurement	 instruments	 were	 identified.	 These	 comprised	 patient	 reported	 outcome	
measures	(n=	31)	and	an	amalgam	of	biologic	measures	and	reports	(n=	28)	(Table	4).	The	
OMERACT	Filter	2.0	framework	mapping	is	outlined	below.		
3.4.		OMERACT	Filter	2.0	core	area	1:	Pathophysiological	manifestations	
Domains	identified	from	this	systematic	review	as	pathophysiological	in	nature	were	
disease	 status,	 effectiveness	 and	 safety	 (Table	3).	 These	were	 further	 subcategorised	 into	
groups	of	 nursing	 sensitive	outcomes	 as	 considered	 appropriate,	 as	 explained	below.	 The	
domain	of	disease	status	had	only	one	nursing	sensitive	outcome,	namely	disease	activity,	
which	was	 assessed	within	 8	 studies	 through	a	 combination	of	 patient	 reported	outcome	
measures	 and	 biologic	 measures	 and	 reports.	 The	 patient	 reported	 outcome	 measures		
included	 joint	 assessment	 using	 the	 composite	 disease	 activity	 score	 (DAS),	 the	 Richie	
articular	 index	 (RAI),	 and	 the	 rheumatoid	 arthritis	 disease	 activity	 assessment	 (RADAI),	
global	 health	 score	 (GH)	 visual	 analogue	 scale	 (VAS),	 physician	 and	 patient	 global	
assessment-VAS,	 and	 patient	 reported	 disease	 activity.	 Biological	 measures	 and	 reports	
included	 c-reactive	 protein	 (CRP),	 erythrocyte	 sedimentation	 rate	 (ESR),	 plasma	 viscosity,	
and	physical	activity	levels	derived	from	walk	time	and	grip	strength	assessments	(Dougados	
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et	al.,	2015,	Hill	et	al.,	1994,	and	Hill,	1997,	Hill	et	al.,	2003,	Maravic	et	al.,	2000,	Ndosi	et	al.,	
2014,	Primdahl	et	al.,	2014,	Ryan	et	al.,	2006,	Tijhuis	et	al.,	2003).		
In	 the	 effectiveness	 domain	 four	 nursing	 sensitive	 outcomes	 were	 identified	 in	 7	
studies,	 namely,	 clinical	 effects,	 pain,	 early	morning	 stiffness	 (EMS)	duration,	 and	 fatigue.	
Clinical	 effectiveness	 as	 a	 domain	 was	 also	 assessed	 through	 a	 combination	 of	 patient	
reported	 outcome	 measures	 and	 biological	 measures	 and	 reports.	 Patient	 reported	
outcome	 measures	 included	 Rheumatology	 Attitude	 Index	 (RAI)	 and	 DAS28.	 Biological	
measures	 included	 biochemical	 measures	 of	 CRP,	 ESR,	 plasma	 viscosity,	 and	 urinalysis;	
radiographic	 imaging	of	hands	and	feet;	self-reported	side	effects.	Pain	and	early	morning	
stiffness	 (EMS)	 were	 assessed	 using	 patient	 reported	 outcome	measures	 only,	 namely,	 a	
pain	 5-point	 ordinal	 scale;	 pain-VAS;	 Arthritis	 Impact	 Measurement	 Scale	 (AIMS);	
Rheumatoid	Arthritis	 Impact	of	Disease	(RAID);	EMS	duration	 in	minutes.	Similarly,	 fatigue	
was	assessed	using	a	fatigue-VAS	and	the	RAID	fatigue	scale	(Dougados	et	al.,	2015,	Hill	et	
al.,	 1994,	 Hill	 et	 al.,	 2003,	Maravic	 et	 al.,	 2000,	 Primdahl	 et	 al.,	 2014,	 Ryan	 et	 al.,	 2006,	
Tijhuis	et	al.,	2003).		
The	 patient	 safety	 domain	 had	 only	 patient	 safety	 issue	 as	 a	 nursing	 sensitive	
outcome,	identified	in	two	studies.	These	were	assessed	by	monitoring	and	documentation	
of	 adherence,	 out	 of	 range	 blood	 tests,	 missing	 relevant	 reaction	 on	 out	 of	 range	 tests,	
RADAI	 alerts,	 Health	 assessment	 Questionnaire-(HAQ)-alerts,	 side-effect	 alerts,	 total	
number	 of	 alerts,	 initiated	 biologic	 treatment,	 telephone	 consultation	 and	 health	 utility	
(Primdahl	et	al.,	2014,	Tijhuis	et	al.,	2003).		
3.5.		OMERACT	Filter	2.0	core	area	2:	Life	Impact	
In	this	area	five	domains	were	identified;	functional,	patient	knowledge,	patient	
satisfaction,	psychological	status	and	quality	of	life	(QoL).		
The	 life	 impact	 domain	 related	 to	 function	 was	 identified	 as	 a	 nursing	 sensitive	
outcome	measured	 through	nine	different	 tools	 across	10	 studies	 (Dougados	et	 al.,	 2015,	
Hill,	1997,	Hill	et	al.,	1994,	Hill	et	al.,	2003,	Maravic	et	al.,	2000,	Ndosi	et	al.,	2014,	Primdahl	
et	 al.,	 2014,	 Ryan	 et	 al.,	 2006,	 Tijhuis	 et	 al.,	 2003,	Watts	 et	 al.,	 2015).	 Patient	 reported	
outcome	measures	 	used	to	assess	 function	 included	the	AIMS;	HAQ-Disability	 index	 (-DI);	
modified	 HAQ	 (mHAQ);	 Nottingham	 Health	 Profile	 (NHP);	 McMaster	 Toronto	 Arthritis	
Patient	 Preference	 Disability	 Questionnaire	 (MACTAR);	 Short-form-12	 (SF-12)	 physical	
health	 composite	 score	 (PSC)	 and	 RAID.	 Biological	 measures	 and	 reports	 used	 to	 assess	
function	included	grip	strength	and	documented	aids	and	adaptations.		
The	 patient	 knowledge	 domain	 had	 one	 nursing	 sensitive	 outcome,	 knowledge,	
measured	in	2	studies	(Hill	et	al.,	1994,	Hill	et	al.,	2003).	This	patient	reported	outcome	was	
measured	 using	 the	 Patient	 Knowledge	 Questionnaire	 (PKQ).	 The	 patient	 satisfaction	
domain	 had	 two	 nursing	 sensitive	 outcomes,	 namely,	 satisfaction	 and	 confidence	 in	 care	
received,	measured	 in	5	studies	 (Arthur	and	Clifford,	2004,	Hill,	1997	and	Hill	et	al.,	1994,	
Hill	et	al.,	2003,	Ndosi	et	al.,	2014,	Primdahl	et	al.,	2014).		
Satisfaction	was	measured	using	patient	 reported	outcome	measures	only,	namely	
the	 Leeds	 Satisfaction	 Questionnaire	 (LSQ),	 a	 satisfaction	 –VAS,	 and	 confidence	 in	 care	
received	–VAS.		
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The	 psychological	 status	 domain	 had	 three	 nursing	 sensitive	 outcomes,	 namely,	
mental	 health,	 self-efficacy	 and	 patient	 attitude/perception	 of	 ability	 to	 control	 arthritis,	
measured	in	6	studies	(Dougados	et	al.,	2015,	Hill,	1997	and	Hill	et	al.,	1994,	Maravic	et	al.,	
2000,	Ndosi	et	al.,	2014,	Primdahl	et	al.,	2014,	Ryan	et	al.,	2006),	using	the	following	patient	
reported	 outcome	 measures	 :	 AIMS,	 NHP;	 SF-12	 mental	 health	 composite	 score	 (MCS);	
arthritis	self-efficacy	scale	Danish	version	(ASES-DK);	rheumatoid	arthritis	self-efficacy	scale	
(RASE);	 rheumatology	 attitude	 index	 (RAI);	 hospital	 anxiety	 and	 depression	 scale	 (HADS),	
and	RAID.		
Quality	 of	 life	 was	 the	 final	 domain	 in	 this	 area	 and	 the	 only	 nursing	 sensitive	
outcome	measured	 in	5	 studies	 (Dougados	et	al.,	 2015,	Maravic	et	al.,	 2000,	Ndosi	et	al.,	
2014,	Primdahl	et	al.,	2014,	Tijhuis	et	al.,	2003),	all	of	which	used	patient	reported	outcomes		
to	 measure	 quality	 of	 life.	 These	 included	 the	 NHP;	 rheumatoid	 arthritis	 quality	 of	 life	
questionnaire	(RAQoL);	the	RAND	36-item	Health	Survey	(RAND-36);	RAID,	and	SF-12.		
3.6.		OMERACT	Filter	2.0	core	area	3:	Resource	Use		
The	domain	 identified	under	resource	use	was	costs	and	had	two	nursing	sensitive	
outcomes,	 namely,	 health	 utility	 and	 health	 care	 resource	 use,	 measured	 in	 5	 studies	
(Dougados	et	al.,	2015,	Ndosi	et	al.,	2014,	Ryan	et	al.,	2006,	Tijhuis	et	al.,	2003,	Watts	et	al.,	
2015).	 The	 patient	 reported	 outcome	 measure	 used	 was	 the	 EuroQoL	 (EQ5D)	 health	
economic	questionnaire,	while	resource	use	was	captured	from	records	of	health	care	data;	
number	 of	 hospitalisations;	 use	 of	 home	 help;	 drug	 use;	 consultation	 with	 other	 health	
professionals;	 changes	 in	 rheumatoid	 arthritis	 disease	 modifying	 anti-rheumatic	 drug	
(DMARD)	therapy,	and	measures	taken	against	co-morbidities.		
3.7.		OMERACT	Filter	2.0	core	area	4:	Death	
Death	had	itself	as	a	domain,	and	as	a	nursing	sensitive	outcomes	was	reported	as	a	
patient	safety	measure	in	1	study	(Primdahl	et	al.,	2014)		
3.8.		Evidence	of	validation	
Out	of	the	59	nursing	sensitive	outcomes	identified,	31	of	these	were	assessed	using	
patient	 reported	 outcome	 measures.	 Evidence	 of	 instrument	 applicability	 in	 the	 chosen	
scope	 is	a	requirement	of	 the	OMERACT	Filter	2.0	 in	the	process	of	core	set	development	
(Boers	et	al.,	2014).	By	and	large,	the	authors	of	the	included	studies	cited	validation	papers	
of	 the	 patient	 reported	 outcome	measures	 used	 within	 their	 studies,	 as	 evidence	 of	 the	
instruments’	validity.		
4. Discussion		
While	outcomes	sensitive	to	the	role	of	nurses	in	general	have	been	studied	before	
(Ingersoll	et	al.,	2000,	Lenz	et	al.,	2004,	Mundinger	et	al.,	2000),	our	study	is	the	first	review	
to	identify	outcomes	that	are	sensitive	to	nursing	intervention	in	patients	with	rheumatoid	
arthritis.	All	outcomes	 identified	were	 in	keeping	with	the	broad	conceptual	 framework	of	
OMERACT	 Filter	 2.0	 encompassing	 pathophysiological	manifestation,	 life	 impact,	 resource	
use	and	economic	impact,	and	death	related	to	rheumatoid	arthritis.	Rheumatology	nurses	
are	 an	 integral	 part	 of	 the	 multidisciplinary	 team	 contributing	 to	 the	 coordination	 and	
delivery	of	patient	 care.	Assessing	 the	 value	of	nursing	 contribution	has	been	a	 challenge	
over	 the	 years	 therefore	 identification	 and	 delineation	 of	 a	 set	 of	 nursing	 sensitive	
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outcomes	and	appropriate	measures	for	capturing	these	outcomes	is	a	positive	contribution	
to	nursing	and	to	patients	with	rheumatoid	arthritis.	Nursing	sensitive	outcomes	may	help	
patients	to	know	what	outcomes	to	expect	from	rheumatology	nursing.	For	the	profession,	
nursing	 sensitive	 outcomes	 will	 help	 demonstrate	 the	 evidence	 of	 rheumatology	 nursing	
effectiveness	so	that	their	contribution	can	be	acknowledged	and	valued.			
Our	 results	 contribute	 to	 advancement	 of	 nursing	 science	 in	 terms	 of	 outcome	
measurement	 in	 rheumatoid	 arthritis	 and	 may	 be	 extended	 to	 other	 inflammatory	
arthritides	(ankylosing	spondylitis	and	psoriatic	arthritis).	 It	 is	 interesting	to	find	that	many	
core	outcomes	measured	in	routine	clinical	care	are	also	sensitive	to	nursing	interventions.	
The	 fact	 that	 nursing	 interventions	 reported	 in	 most	 included	 studies	 involved	 disease	
management	as	part	of	holistic	care	may	account	for	this.	Working	in	extended	role	capacity	
blurs	 the	 professional	 boundaries	 in	 order	 to	 meet	 patients’	 needs;	 therefore	 it	 is	 not	
surprising	 that	 most	 routine	 clinical	 outcomes	 (such	 as	 disease	 activity,	 pain,	 morning	
stiffness	 and	 fatigue)	 were	 also	 nursing	 sensitive	 outcomes.	 It	 is	 worth	 mentioning	 that	
nurses’	 roles	 differ	 across	 countries	 depending	 on	 legal	 frameworks,	 health	 policy	 and	
funding	 for	 health,	 and	 differences	 in	 educational	 systems.	While	 extended	 roles	 are	 not	
practised	 everywhere	 and	 studies	 often	 lack	 an	 extensive	 description	 of	 nurses’	 roles	 and	
responsibilities,	 it	 is	 still	 important	 to	 delineate	 nursing	 sensitive	 outcomes	 as	 these	 may	
contribute	towards	the	development	of	more	detailed	recommendations	for	the	role	of	the	
nurse	in	the	care	of	people	with	rheumatoid	arthritis.	
While	 routine	 clinical	 outcome	 measures	 were	 identified,	 the	 number	 of	 patient	
reported	outcome	measures	was	many	and	varied.	Further	research	is	warranted	to	test	the	
properties	 of	 each	 patient	 reported	 outcome	 measure,	 within	 the	 context	 of	 nursing	
sensitive	 outcomes.	 Then,	 recommendations	 can	 be	 made	 as	 to	 which	 patient	 reported	
outcome	 measures	 should	 be	 used	 to	 best	 assess	 aspects	 of	 care	 when	 evaluating	 the	
impact	of	rheumatology	nursing.	Appropriate	measures	would	include	those	focused	on	the	
ten	nursing	domains	 reported	here	 i.e.	 (i)	 disease	 status,	 (ii)	 effectiveness,	 (iii)	 safety,	 (iv)	
function,	 (v)	 knowledge,	 (vi)	 satisfaction,	 (vii)	 psychological	 status	 (viii)	 quality	 of	 life,	 (ix)	
costs	and	(x)	death.	Although	death	was	reported	in	one	study	(Primdahl	et	al.,	2014),	this	
was	 not	 presented	 as	 an	 outcome	 of	 the	 interventions.	 All	 clinical	 trials	 are	 required	 to	
report	all	serious	events	(including	death)	therefore	making	death	an	implicit	outcome	in	all	
clinical	 studies.	 Our	 results	 provide	 a	 good	 foundation	 upon	 which	 to	 develop	
methodologically	sound	research	designs	to	further	examine	the	multidimensional,	complex	
and	 complementary	 role	 that	 rheumatology	 nursing	 plays	 in	 the	 care	 of	 people	 with	
rheumatoid	arthritis	(Campbell	et	al.,	2000,	Craig	et	al.,	2008).	
The	 importance	 of	 outcome	 research	 and	 the	 challenges	 of	 identifying	 outcomes	
sensitive	to	advanced	nursing	practice	have	been	discussed	(Kleinpell	and	Gawlinski,	2005,	
Resnick,	 2006).	 These	 reports	 reflect	 the	 evolution	 of	 rheumatology	 nursing	 practice	 into	
what	 can	 be	 described	 as	 multilevel	 nursing	 practice	 (Begley	 et	 al.,	 2010).	 With	 this	
evolution	of	nursing	practice	comes	the	seminal	caveat	which	urges	nurses	to	capture	both	
the	art	and	science	of	high	 level	nursing	care	 (Wiedenbach,	1963).	The	question	as	 to	 the	
‘added	 value’	 the	 ‘art	 of	 nursing’	 brings	 to	 bear	 on	 patient	 outcome	 remains	 a	 challenge	
which	our	 research	 is	only	beginning	 to	address	with	 respect	 to	patients	with	 rheumatoid	
arthritis.	This	challenge	of	capturing	both	the	easily	identifiable	quantitative	outcomes	and	
the	unspecified,	qualitative	aspects	of	nursing	care	has	been	noted	by	Gerrish	(2011).	One	
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proposed	 approach	 used	 to	 comprehensively	 evaluate	 the	 impact	 of	 advanced	 practice	
nursing	 is	 a	 model	 which	 encompasses	 (i)	 symptomatology,	 (ii)	 quality	 of	 life,	 (iii)	 social	
significance,	and	 (iv)	 social	validity	 (Begley	et	al.,	2010,	Gerrish,	2011,	Schulz	et	al.,	2002).	
Another	approach	is	to	use	the	‘complex	interventions	framework’	to	assess	structure	and	
process	of	care	in	addition	to	outcomes	(Campbell	et	al.,	2000,	Campbell	et	al.,	2007,	Craig	
et	al.,	2008).	This	would	require	mixed	methods	research	in	order	to	capture	the	role	of	the	
rheumatology	 nurse	 in	 providing	 added	 value	 to	 the	 care	 of	 patients	 with	 the	 chronic,	
potentially	 debilitating	 rheumatic	 disease	 that	 is	 rheumatoid	 arthritis.	 Findings	 from	 this	
study	provide	a	basis	for	such	further	research.	
4.1.		Strengths	and	limitation	of	the	review		
Strengths	of	this	review	include	the	use	of	the	OMERACT	Filter	2.0	as	the	overarching	
conceptual	 framework	 for	 health.	 This	 framework	 is	 respected	 across	 the	 rheumatology	
communities	where	 it	has	been	 in	use	since	1992.	 It	was	the	framework	of	choice	for	this	
review	so	as	to	maintain	alignment	with	the	wider	rheumatology	community.	Both	another	
strength	 and	 attraction	 is	 the	 involvement	 of	 multinational	 researchers	 and	 active	
involvement	of	patient	partners	 in	the	OMERACT	review	process	 in	keeping	with	what	has	
become	 international	 best	 practice	 (de	Wit	 et	 al.,	 2011,	 Kirwan	 et	 al.,	 2008,	 Speight	 and	
Barendse,	 2010).	 The	 patient	 research	 partners	 participated	 as	 full	 researchers	 in	 the	
discussion	 about	 the	 necessity	 of	 this	 work;	 design	 of	 the	 review;	 study	 selection	 and	 in	
finalising	 the	 manuscript	 therefore	 their	 involvement	 ensured	 that	 the	 nursing	 sensitive	
outcomes	identified	were	relevant	to	patients	(de	Wit	et	al.,	2011).	The	main	limitations	of	
this	review	include	its	confinement	to	RCTs,	cohort	studies	and	one	cross-sectional	study	in	
English	language	only.	As	the	aim	of	the	study	was	specifically	to	measure	nursing	sensitive	
outcomes	and	the	tools	used	for	their	measurement	qualitative	studies	were	excluded.	This	
exclusion	of	qualitative	studies	is	likely	to	have	missed	an	opportunity	to	determine	aspects	
of	nursing	practice	not	ordinarily	reported	in	RCTs,	especially	the	‘structure’	or	 ‘processes’	
of	care	both	of	which	contribute	to	patient	outcomes	(Campbell	et	al.,	2000,	Campbell	et	al.,	
2007,	Craig	et	al.,	2008).	Not	all	studies	gave	enough	detail	about	the	role	of	the	nurse	in	the	
development,	 delivery	 and	 testing	 of	 the	 varied	 interventions.	 Therefore,	 this	 review	 can	
only	confirm	that	nurses	had	a	role	in	the	interventions.	Furthermore,	as	this	review	did	not	
intend	to	delineate	the	role	of	the	members	of	the	multidisciplinary	team,	we	acknowledge	
that	nursing	 sensitive	outcomes	are	not	exclusive	 to	nursing,	 as	 the	 contribution	of	other	
healthcare	professionals	may	also	influence	these	outcomes.				
5. Conclusions	
This	 systematic	 literature	 review	 identified	 the	 extent	 and	 nature	 of	 recognised	
patient	 outcomes	 in	 rheumatoid	 arthritis	 that	 may	 be	 affected	 by	 rheumatology	 nursing	
interventions.	 Furthermore,	 the	 review	 provides	 robust	 evidence	 that	 the	 delineated	
validated	 instruments,	 used	 in	 RCTs	 and	 increasingly	 in	 routine	 clinical	 practice,	 are	
appropriate	for	use	in	all	studies	which	aim	to	evaluate	the	impact	of	nursing	interventions	
on	 patient	 outcome	 in	 rheumatoid	 arthritis.	 The	 alignment	 of	 these	 nursing	 sensitive	
outcomes	 to	 the	 OMERACT	 conceptual	 framework	 confirms	 how	 nursing	 impacts	 all	
domains	of	health	in	this	potentially	debilitating	chronic	disease.		
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Our	study	therefore	is	the	foundation	step	in	the	development	of	an	agreed	upon	core	
set	of	outcomes	to	be	measured	 in	all	nursing	 intervention	studies	 involving	patients	with	
rheumatoid	 arthritis.	 Further	 research	 is	 needed	 to	 strengthen	 our	 knowledge	 about	 the	
contributions	of	nursing	sensitive	outcomes	to	the	OMERACT	Filter	2.0.	Moreover,	 further	
exploratory	study	is	required	to	more	comprehensively	examine	aspects	of	patient-centered	
care	 unique	 to	 rheumatology	 nursing	 in	 order	 to	 optimise	 the	 impact	 of	 nursing	 both	 in	
promoting	 health	 and	 caring	 for	 patients	with	 rheumatoid	 arthritis	 and,	 by	 extension,	 all	
patients	with	chronic	rheumatic	diseases.				
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Figure	1:	Concepts,	Core	Areas,	and	Domains	for	outcome	measurement	in	health	intervention	studies.		
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Figure	2:	Study	flow	diagram	
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Table	1:	Identified	and	defined	context	specific	nursing	sensitive	outcomes	and	domains	mapped	to	OMERACT	conceptual	framework		
Nursing	sensitive	
outcomes		
Domains	identified		
in	the	context	of	
rheumatoid	
arthritis	
Definition	of	context	specific	domains	 OMERACT		
Core	Area	
OMERACT	domains		and	
examples	relevant	for	
rheumatoid	arthritis	
Disease	activity	
	
Disease	status	 All	direct	measures	to	monitor	disease	and	
treatment	such	as	swollen	and	tender	joints,	
biomarkers	such	as	ESR	or	CRP,	patient	and	clinicians	
opinions	about	disease	activity,	but	also	indirect	
measures	such	as	grip	strength	and	ability	to	walk,	
as	surrogate	markers	for	disease	activity.	
Pathophysiological	
manifestations	
Organ	function:	joint	
inflammation																		
	
Reversible	manifestations:	out	of	
range	blood	tests,	medication	
related	adverse	events.	
	
Irreversible	manifestations:	
radiographic	joint	damage.		
	
Biomarkers	and	surrogate	
outcomes:	ESR,	CRP,	radiographic	
images	of	joints,	urine	analysis	
indicative	of	drug	induced	renal	
disease,	grip	strength	and	walk	
ability.	
Clinical	effects	
Pain		
Stiffness	
Fatigue	
Effectiveness	 Clinical	effects	on	disease	status	but	also	on	
patients’	symptoms	such	as	pain,	stiffness,	fatigue.	
Patient	safety	
issues	
Safety	 Patient	safety	issues	related	to	the	disease,	the	
treatment	or	the	patient	health	condition	in	general.	
Function	(physical)	
Patient	knowledge	
Functional	 Effects	on	the	patient’s	functional	health	status	and	
mental	health	status,	perceived	health	but	also	more	
indirect	measures	that	can	contribute	to	a	better	
Life	Impact	 Activity	and	participation	
Quality	of	life	
	
	
19	
	
Patient	satisfaction	
Psychological	
status	
Quality	of	Life	
perception,	such	as	knowledge.	 Patient	perception	of	health	
Psychosocial	impact	
Health	utility	
Healthcare	
resources	
Costs	 Direct	and	indirect	healthcare	costs	and	health	utility	
for	economic	/cost-effectiveness	evaluations.	
Resource	Use	 Costs	
Death*	 Death	 All	reported	causes	of	death:	disease	related;	
treatment	related	or	other.	
Death	 Death	
*Reporting	mortality	is	a	regulatory	requirement	for	all	clinical	studies.	
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Table	2.	Characteristics	of	included	studies,	nursing	sensitive	outcomes,	measurement	instruments	and	results		
Publication	
Country	
Participants	
Study	Aim,	Setting,	Design,	
and	Method	
Nursing	Sensitive	Outcomes	
(Measurement	Instruments)	
Results	
Arthur	and	
Clifford	
(2004)	
	
		UK	
	
80	patients,	on	disease-
modifying	antirheumatic	
drugs	(DMARDS)		
	
76%	female	
Cross	sectional	comparison	of	
satisfaction	with	routine	follow-
up	between	two	groups.		
i)			Rheumatology	Nurse	Specialist	
(RNS)	in	secondary	care	
ii)		General	practitioner	in	primary	
care	
	
Patient	questionnaire	
	
Descriptive	and	bivariate	statistics	
• Patient	satisfaction		
														(Leeds	Satisfaction	
Questionnaire)	
	
• Knowledge	of	drug	therapy		
(No	instrument	listed)	
	
• Knowledge	of	monitoring	
requirements	
	(No	instrument	listed)	
	
• Knowledge	of	drug	effects		
	(No	instrument	listed)	
Significant	improvements	in	the	
RNS		secondary	care	group	for:		
• satisfaction		(overall,	
information,	empathy,	
technical	quality,	
attitude,	access)	
	
No	significant	between	group	
differences	in:	
• knowledge	of	drug	
therapy,	knowledge	of	
monitoring	
requirements	
	
Significant	improvements	
(reported	without	statistics)	in	
the	RNS	secondary	care	group	
in:	
• knowledge	of	drug	
effects	
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Dougados	et	
al.	(2015)	
	
France	
970	patients	
	
79%	female	
	
	
Randomised	Controlled	Trial	
(RCT),	comparing	patient	
outcome	of	two	active	
intervention	arms:	
i)	nurse	led	programme	on	
comorbidity	(NLC)		
ii)	patient	self-assessment	of	
disease	activity	(PSD)		
	
Six	months	duration	
	
Patient	notes/booklet	and	
questionnaires	
	
Mixed	logistical	regression	
analysis	
	
	
	
• Disease	activity	(DAS28)-
ESR			
• Functional	status	(MHAQ)	
• Quality	of	life	Rheumatoid	
Arthritis	Impact	of	Disease	
(RAID)		
• Number	of	measures	taken	
against	co-morbidities	
• Number	of	medication	
changes	for	RA		
No-significant	between	group	
difference	in:		
• DAS28-ESR	
• MHAQ	
• RAID	
	
Significant	between	group	
differences	in	favour	of	the		
NLC	group	in:	
• number	of	measures	
taken	against	co-
morbidities	
(cardiovascular	disease,	
cancer,	infections,	
osteoporosis)	
	
Significant	between	group	
differences	in	favour	of	the		
PSD	group	in:	
• number	of	medication	
changes	(increase	in	
DMARD	therapy	
changes)		
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Hill	et	al.	
(1994),	Hill	
(1997)	
	
UK		
70	patients	
		
74%	female		
RCT	comparing	the	effectiveness,	
safety	and	acceptability	of:	
i)	Rheumatology	Nurse	
Practitioner	(RNP)		
ii)	consultant	rheumatologist	care		
	
Outpatient	clinic	for	up	to	48	
weeks		
	
Data	from	patients’	notes	and	
patient	questionnaire		
	
Bivariate	analyses		
	
• Arthritis	Impact	
Measurement	Scales	
(AIMS)		
• Patient	Knowledge	
Questionnaire	(PKQ)			
• Patient	Satisfaction	by	
Leeds	Satisfaction	
Questionnaire			
	(LSQ)	
• Safety/effectiveness,	
Plasma	Viscosity	(PV),	C-
Reactive	Protein	(CRP),	
urinalysis		
• Richie	Articular	Index	(RAI)	
• Early	Morning	Stiffness	
duration	(EMS)		
• Pain	(5	point	ordinal	scale)	
	
Significant	between	group	
differences	in	favour	of	the		
RNP	group	in:	
• PKQ		
• Patient	Satisfaction	
(overall,	information,	
empathy,	technical	
quality,	attitude,	access)	
	
No	significant	between	group	
differences	in:	
• PV,	CRP,	RAI,	EMS,	pain,			
• AIMS	(depression,	
anxiety)		
	
Hill,	(2003)	
	UK	
	
80	patients		
79%	female	
		
RCT	comparing	outcomes	of:	
i)	Rheumatology	nurse	
practitioner	RNP		
ii)	Junior	hospital	doctor	(JHD)		
	
Outpatient	clinic	for	up	to	48	
• Disease	activity	(DAS28)		
• Fatigue	(Duration	in	
minutes),	
• Morning	stiffness	(Duration	
in	minutes)	
• Pain	(VAS),	physical	
function,		
psychological	status	(AIMS)		
• Knowledge	(PKQ)		
• Satisfaction	(LSQ)	
Significant	between	group	
outcomes		in	favour	of	RNP	
group	in:	
• Fatigue	–	improved	(p	=	
0.038)		
• Knowledge		
• Pain-decreased	(p	=	
0.044)	
• Satisfaction	(access	and	
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weeks.		
	
Patient	notes	and	patient	
questionnaires.		
	
Bivariate	analyses.	
	
	
	
• Plasma	viscosity,	
• Articular	index	(28	swollen	
and	tender	joint	count),	
	
	
	
	
	
	
	
	
continuity)	
	
Significant	between	group	
outcomes	in	favour	of	the	JHD	
in:	
• Physical	function:	
Significant	deterioration	
	
No	significant	between	group	
differences	or	outcomes	in:	
• Plasma	viscosity			
• Articular	index	
• Morning	stiffness	
• Psychological	status			
This	RCT’s	findings	indicate	
RNP	care	as	compared	to		
JHD	care	is	effective	and	safe	
with	increased	patient	
satisfaction,	better	symptom	
control	and	self-care	
improvement	
	
Maravic	et	al.,	
(2000)			
	
France		
20	patients	
		
80%	Female		
Cohort	study	of	medical	
outcomes	and	quality	of	life	over	
6	months	
	
3	types	of	in-patient	direct	nurse	
• Pain	(VAS	)	
• Disease	activity	by	patient	
(VAS)		
• DAS28	
• ESR,	CRP	
• Quality	of	life	(NHP)	
• Function	(HAQ)	
Significant	improvements		
in	outcomes		for:	
• Pain	
• Disease	activity	by	patient	
• Disease	activity	(tender	
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	 care	were	recorded:	
	i)	basic	care		
ii)	technical		
iii)	support/education	
		
Patient	notes	and	questionnaires	
	
Bivariate	analyses		
• AIMS	
	
and	swollen	joint	count	,	
ESR,	CRP)	
• NHP		
• HAQ		
	
AIMS	(physical	and	symptoms	
only)	
Ndosi,	(2014)		
	
UK	
	
181	patients		
	
70%	female		
	
	
	
	
	
	
RCT	comparing	the	effectiveness	
and	cost-effectiveness	of:	
i)	nurse-led	care	(NLC)	
ii)	rheumatologist-led	care	(RLC)			
	
Outpatient	follow	up	care	to	52	
weeks	
	
Patient	notes	and	questionnaire	
		
Linear	regression	(controlling	for	
• Primary	outcome:		
Improvement	in	disease	
activity	(Change	in	DAS28)	
	
• Secondary	outcomes:		
														Pain	(VAS)	
															Fatigue	(VAS)			
														Morning	stiffness	
													(duration	in		minutes)		
															Quality	of	life	(RAQoL)		
															Function	(HAQ-DI	)	
															Anxiety	and	depression	
Non-inferiority	of	the	NLC	
confirmed	based	on:	
• Average	changes	in	DAS28	
scores	at	52	weeks	
(primary	outcome)	
• Pain	
• Fatigue	
• Stiffness	
• Quality	of	life	
• Function	and		
• Anxiety	 and	
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age	gender,	centre,	baseline,	
DAS28).	
	
															(HADS)	
															Arthritis	self-efficacy		
															(ASES)		
															Patient	satisfaction	(LSQ)	
														Cost		
															EQ5D)	
Record	of	health	care	
resource	data.	
depression	
• Self-	efficacy	
Significant	between	group	
differences	in	favour	of	the		
NLC	in	satisfaction	and	costs	at	
52	weeks	
	
	
Primdahl	
(2014)	
	
Denmark	
	
287	patients		
	
70%	female		
	
	
RCT	comparing	patient	outcomes	
of	three	groups:		
i)	planned	rheumatologist	
consultation	
ii)	shared	care	without	planned	
consultations		
iii)	planned	nursing	consultations	
	
Follow	up	care	for	two	years	
		
Low	disease	activity	patients		
• Primary	outcome	:		
Disease	Activity	Score	with	28	joint	
measurement	(DAS28-CRP,	Visual	
Analog	Scale	(VAS)	patient	global	
score,	joint	examinations	of	ankles	
and	feet)	
	
• Secondary	outcomes	(SO):		
Self-efficacy	by	the	RA	Self-Efficacy	
Questionnaire	(RASEQ),	Arthritis	
Self-Efficacy	Scale-Danish	version	
(ASES-DK)	(pain,	function)	
Function	by	the		Health	
Assessment	Questionnaire	(HAQ)	
Significant	between	groups	
differences	in	favour	of	nurse	
consultation	group	in:	
	
Primary	outcomes:		
• Lower	disease	activity	(2	
year),	in	favour	of		nursing	
consultations	
	
Secondary	outcomes:		
Increased	Self-efficacy	
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Patient	notes	and	questionnaires		
	
Logistical	regression	controlling	
for	interactions		
	
Global	Health	from	(VAS)		
Pain	by	(VAS)	
Fatigue	by	(VAS)	
Quality	of	life	(Short	form	12	
Physical	Health	Composite	(PCS)	&	
Mental	Health	Composite	(MCS)		
Satisfaction	by	(VAS)	
Confidence	in	care	received	(VAS)	
RA	disease	activity	index	(RADAI)	
Self-reported	side	effects		
	
Initiated	biologic	treatments		
Death		
(ASES-DK)	(1	and	2	years)		
Increased	Confidence	(2	year	
only),		
• Increased	Satisfaction	(1	
and	2years,		
• All	in	favour	of	nursing	
consultations	
	
	
Ryan,	(2006)			
	
UK	
71	patients	
		
starting	on		DMARDS	
		
56%	female		
RCT	comparing	the	effect	on	
wellbeing	of:	
i)	nurse-led	clinical	nurse	
specialist	(CNS)	drug	monitor	
clinic		
ii)	rheumatologist-led	clinic	for	52	
weeks	
• Health	status	(physical	
function,	psychological	
distress,	AIMS)			
• Patients’	perceptions	of	
ability	to	control	their	
arthritis	(RAI)	
• Disease	activity	(DAS)			
• Consultation	with	other	
health	care	professionals	
(Self-developed	non-
No	significant	difference	between	
groups	at	52	weeks	in:	
• AIMS	
• RAI	
• Number	of	
consultations,		
• NSAIDS,	DMARDS,	
steroid	usage	
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Patient	notes	and		questionnaire	
		
Linear	regression	(controlling	for	
demographics	and	baseline	
clinical	values)	
validated	questionnaire	(no	
statistics	provided)	
	
Significant	between	group	
differences	in	favour	of	nurse	
group	in:	
• Improved	DAS	at	52	weeks	
	
	
Tijhuis,	(2003)		
	
The	
Netherlands	
	
210	patients	
		
With	increasing	difficulty	
with	Activities	of	Daily	
Living	(ADL’s)	over	last	six	
weeks		
	
79%	female		
		
RCT	comparing	the	effectiveness	
of	care	across	three	groups:			
i)	clinical	nurse	specialist	care	
(CNS)	ii)	in-patient	team	care	(IPT)		
iii)	day-patient	team	care	(DPT)	
				
Two	year	follow	up	
		
Patient	notes	and	questionnaires	
		
Bivariate	analyses	(adjusted	for	
age	and	differences	at	baseline)		
• Functional	status	(HAQ,		
MacMaster	Toronto	
Arthritis	patient	preference	
interview	(MACTAR)	
• Quality	of	life	(RAND-36	
(physical	and	mental))		
• RA	quality	of	life	(RAQoL),	
• Grip	strength			
• Walk	test	
• Disease	activity(DAS)	
• Health	utility	(Uptake	of	
paramedic	services:	
Physiotherapist,	
occupational	therapist,	
social	worker,	CNS),	
• home	adaptations		
• number	of	hospitalisations			
• use	of	home	help,	drug	use	
No	significant	between	groups	
differences		with	improvement	
of	outcomes	in	all	groups	over	
time	in:	
• HAQ	
• RAND	36	–	Physical	and	
Mental	
• RAQoL	
• Grip	
• Walk	
• DAS	
Significant	between	groups	
differences	in	favour	of	CNS	
group	in:	
• MACTAR		(yr1)	
• Receiving	home	help		
(yr	2)	
• Number	of	nurse	visits	
(yrs		1	&	2)	
Significant	between	groups	
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differences	in	favour	of	IPT		
group	in:	
• Functional	Status	–	yr		1	
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Watts	et	al.	
(2015)	
	
UK	
349	patients	
	
70%	female	
	
	
Cohort	study	of	the	cost-
effectiveness	and	outcomes	of:	
i)	community	nurse-led	care	(NLC)		
ii)	rheumatologist	led	out-patient	
care	(RLC)	for	rheumatoid	
arthritis,	thereby	reflecting	real	
life	
care	
12	month	duration	
Questionnaires	
Linear	regression	analyses.	
• Functional	status	using	
Stanford	health	assessment	
questionnaire	(HAQ)	
• Economic	evaluation	
(healthcare	perspective)	
estimated	cost	relative	to	
change	in	HAQ	and	quality-
adjusted	life	years	(QALY)	
derived	from	EuroQoL-5D		
(EQ-5D-3L).	
No	significant	between	group	
differences	in	:	
• Functional	status	(HAQ,	
QALY)	
														NLC	group:	HAQ	
															and			QALY		
	
• Cost:		
Abbreviations	in	alphabetical	order	:	AIMS:	Arthritis	Impact	Measurement	Scale,	ASES,	Arthritis	Self-Efficacy	Scale,	CNS:	clinical	nurse	specialist	CRP:	C-
reactive	protein,DAS28:	Disease	Activity	Score	28	joints,	DMARDS:	Disease	Modifying	Anti	Rheumatic	Drugs;	EMS:	early	morning	stiffness	duration,,	ESR:	
erythrocyte	sedimentation	rate,		HADs:	Hospital	anxiety	and	depression	scale,	HAQ-DI:	health	assessment	questionnaire	disability	index,	LSQ,	Leeds	
Satisfaction	Questionnaire,	MACTAR:	McMaster	Toronto	Arthritis	Patient	Preference	Disability	Questionnaire,	MCS:	Mental	health	composite	score,	MHAQ	
Modified	Health	Assessment	Questionnaire,	NHP:	Nottingham	Health	Profile,	NSAIDS:	Non-steroidal	anti-inflammatory	drugs,	PKQ:	Patient	Knowledge	
Questionnaire,	PCS:	Physical	health	composite	score,	RADAI	:	rheumatoid	arthritis	disease	activity	index,	RAI:	Rheumatology	Attitude	Index,	RAID	
Rheumatoid	Arthritis	Impact	of	Disease	RAND:	RAND	36-item	Health	Survey,	RCT:	randomised	controlled	trial;	RAQoL:	Rheumatoid	Arthritis	Quality	of	Life	
Scale,	RASEQ:	Rheumatoid	arthritis	self-efficacy	questionnaire,	TJC:	Tender	joint	count,	SJW:	swollen	joint	count,	RNS:	rheumatology	nurse	specialist,	RNP:	
rheumatology	nurse	practitioner,	VAS:	visual	analogue	scale.		
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Table	3	Critical	appraisal	skills	programme	(CASP)	results	of	included	studies		
Ap
pr
ai
sa
l	q
ue
st
io
ns
	
Trials	
Do
ug
ad
os
		e
t	a
l.,
	2
01
5	
	
Hi
ll	
et
	a
l.	
19
94
,	H
ill
	1
99
7	
	
Hi
ll,
	2
00
3	
	
	 Nd
os
i,	
20
14
	
Pr
im
da
hl
	2
01
4	
Ry
an
,	2
00
5	
Ti
jh
ui
s,	
20
03
	
Ap
pr
ai
sa
l	q
ue
st
io
ns
	
Cross	Sectional*	
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1	 Did	the	trial	
address	a	clearly	
focused	issue?		
1	 1	 1	 1	 1	 1	 1	 1	 Did	the	study	/	
trial	address	a	
clearly	focused	
issue?		
1	 1	 1	
2	 Was	the	
assignment	of	
patients	to	
treatment	
1	 1	 1	 1	 1	 1	 1	 2	 Was	the	cohort	
recruited	in	an	
acceptable	way?		
2	 1	 1	
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randomised?	
3	 Were	all	the	
patients	who	
entered	the	trial	
accounted	for	in	
the	conclusion?		
1	 2	 2	 1	 1	 1	 1	 3	 Was	the	exposure	
accurately	
measured	to	
minimize	bias?		
1	 NA	 1	
4	 Were	patients,		
health	workers	
and	study	
personnel	blind	to	
treatment				
1	 1		 1		 1	 1	 1	 1	 4	 Was	the	outcome	
accurately	
measured	to	
minimize	bias?		
1	 1	 1	
5	 Were	all	the	
groups	similar	at	
the	start	of	the	
2	 3	 1	 2	 1	 1	 1	 5a	 Have	the	authors	
identified	all	
important	
3	 3	 1	
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trial?		 confounding	
factors?		
6	 Aside	from	the	
experimental	
intervention	were	
the	groups	treated	
equally?		
1	 2	 1	 1	 1	 2	 2	 5b	 Have	they	taken	
account	of	the	
confounding	
factors	in	the	
design	and/or	
analysis?		
3	 3	 1	
7		 How	large	was	the	
treatment	effect#	
1	 1	 1	 1	 1	 1	 1	 6a	 Was	the	follow	up	
of	subjects	
complete	
enough?		
1	 1	 1	
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8		 How	precise	was	
the	estimate	of	
the	treatment	
effect?*	
1	 3	 3	 1	 1	 1	 1	 6b	 Was	the	follow	up	
of	subjects	long	
enough?		
NA	 1	 1	
9	 Can	the	results	be	
applied	in	your	
context/	local	
population?		
1	 1	 1	 1	 1	 1	 3	 7	 What	are	the	
results	of	this	
study?		
1	 1	 1	
10	 Were	 all	 the	
clinically	
important	
outcomes	
considered?		
1	 1	 1	 1	 1	 1	 1	 8	 How	precise	are	
the	results?		
2	 2	 1	
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11		 	Are	the	benefits	
worth	the	harms	
and	costs?				
1	 1	 1	 1	 1	 1	 1	 9	 Do	you	believe	
the	results?		
1	 1	 1	
	 	 	 	 	 	 	 	 	 10	 Can	the	results	be	
applied	to	the	
local	population?		
1	 1	 1	
	 	 	 	 	 	 	 	 	 11		 Do the results of 
this study fit with 
other available 
evidence? 	
1	 1	 1	
	 Total	number	of	
yes	responses	
10	 7	 9	 10	 11	 10	 9	 	 Total			 8	 9	 11	
	 	 	 	 	 	 	 	 	 	 	 	 	 	
1	=	Yes,	2	=	Cant’	tell,	3	=	No,	NA	=	not	applicable;	#	1=	Clear	result	,	2	=Can’t	tell,	3=	Unclear;	*	1=	Precise,	2	=Can’t	tell,	3=	Imprecise		
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Table	4	Identified	nursing	sensitive	outcomes	and	measurement	instruments	categorised	into	domains	and	core	areas	according	to	the	
OMERACT	Filter	2.0	
OMERACT	
framework	
Domains	
Nursing	
sensitive	
outcomes	
Measurement	instruments	(Reference	papers)	
Core	Areas	n=4	 n=10	 n=17	 Patient	reported	outcomes	measures	(n=31)	 Biologic	measures	and	reports	(n=28)	
Pathophysiological	
manifestations	
Disease	status	 Disease	activity	 DAS28*	(Dougados	et	al.,	2015,	Hill	et	al.,	1994,	Hill	et	
al.,	2003,	Ndosi	et	al.,	2014,	Primdahl	et	al.,	2014,	
Ryan	et	al.,	2006,	Tijhuis	et	al.,	2003).			
CRP	and	ESR	(Hill	et	al.,	
1994,	Hill	et	al.,	2003,	
Maravic	et	al.,	2000).	
RAI*	(Hill,	1997,	Hill	et	al.,	1994).	 Plasma	viscosity	(Hill	et	
al.,	1994,	Hill	et	al.,	
2003).	
RADAI*	(Primdahl	et	al.,	2014)	 Walk-time	(Maravic	et	
al.,	2000,	Tijhuis	et	al.,	
2003).	
Global	health	score	–VAS	(Primdahl	et	al.,	2014)	 Grip	strength	(	Tijhuis	et	
al.,	2003)	
Disease	activity	evaluated	by	physician	and	patient	
(VAS	100-mm)(Maravic	et	al.,	2000)	
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		 Effectiveness	 Clinical	effects	 Articular	indices*	(RAI	and	28	TJC,	SJC)	(Hill	et	al.,	
2003,	Maravic	et	al.,	2000,	Primdahl	et	al.,	2014).	
Plasma	viscosity	(Hill	et	
al.,	1994,	Hill	et	al.,	
2003)	
DAS28*	(Dougados	et	al.,	2015,	Hill	et	al.,	2003,	Ryan	
et	al.,	2006).	
CRP	and	ESR	(Hill	et	al.,	
1994,	Hill	et	al.,	2003,	
Maravic	et	al.,	2000)	
	
	 Urinalysis		(Hill	et	al.,	
1994)	
	 X-ray	hands	and	feet	
(Primdahl	et	al.,	2014,	
Tijhuis	et	al.,	2003)	
	
	 	 	 	 Self-reported	side	
effects	(Primdahl	et	al.,	
2014)	
	
		 	 Pain	 Pain	5	point	ordinal	scale	(Hill,	1997,	Hill	et	al.,	1994).	 		
Pain	VAS	(Hill	et	al.,	2003,	Maravic	et	al.,	2000,	Ndosi	
et	al.,	2014).	
AIMS*	(Hill	et	al.,	1994,	Hill	et	al.,	2003,	Maravic	et	al.,	
2000,	Ryan	et	al.,	2006).	
RAID*	(Dougados	et	al.,	2015)	
	
	
37	
	
		 	 Stiffness	 EMS	duration	in	minutes	(Hill	et	al.,	1994,	Hill	et	al.,	
2003,	Ndosi	et	al.,	2014)	
		
		 	 Fatigue	 Fatigue	VAS	(Ndosi	et	al.,	2014)	 		
RAID*	(Dougados	et	al.,	2015)	
		 Safety	 Patient	safety	
issues	
		 	Adherence	(Primdahl	et	
al.,	2014)	
	 	 Out	of	range	blood	tests	
(Primdahl	et	al.,	2014)	
	 	 Missing	relevant	
reaction	on	out	of	range	
tests	(Primdahl	et	al.,	
2014)	
	 	 RADAI	alerts	(Primdahl	
et	al.,	2014)	
	 	 HAQ-alerts	(Primdahl	et	
al.,	2014)	
	 Side-effect	alerts	
(Primdahl	et	al.,	2014)	
	 	 Total	number	of	alerts	
(Primdahl	et	al.,	2014),	
	 	 Initiated	biologic	
treatment	(Primdahl	et	
al.,	2014),	
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	 	 Telephone	consult	
(Primdahl	et	al.,	2014,	
Tijhuis	et	al.,	2003)	
	 	 Health	utility	(Tijhuis	et	
al.,	2003)	
Life	Impact	 Functional	 Function	
(physical)	
AIMS*	(Hill	et	al.,	1994,	Hill	et	al.,	2003,	Maravic	et	al.,	
2000,	Ryan	et	al.,	2006).	
Grip	strength	(Tijhuis	et	
al.,	2003)	
HAQ-DI*	(Maravic	et	al.,	2000,	Ndosi	et	al.,	2014,	
Primdahl	et	al.,	2014,	Tijhuis	et	al.,	2003,	Watts	et	al.,	
2015).	
Aids	and	adaptations	
(Tijhuis	et	al.,	2003)	
mHAQ*(Primdahl	et	al.,	2014)	 		
NHP*	(Maravic	et	al.,	2000,	Primdahl	et	al.,	2014)	 		
MACTAR*	(Tijhuis	et	al.,	2003)	 		
SF-12	(PCS)*	(Primdahl	et	al.,	2014,	Tijhuis	et	al.,	2003)	 		
RAID*	(Dougados	et	al.,	2015)	 		
		 Patient	
knowledge	
Knowledge	 PKQ	*(Hill	et	al.,	1994,	Hill	et	al.,	2003)	 		
		
		
Patient	
satisfaction	
Satisfaction	 LSQ*	(Arthur	and	Clifford,	2004,	Hill,	1997,	Hill	et	al.,	
1994,	Hill	et	al.,	2003,	Ndosi	et	al.,	2014).	
		
	 Satisfaction	–VAS	(Primdahl	et	al.,	2014)	
Confidence	in	
care	received	
Confidence	in	care	received-VAS	(Primdahl	et	al.,	
2014)	
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Psychological	
status	
Mental	health	
status	
AIMS*	(Hill	et	al.,	1994,	Hill	et	al.,	2003,	Maravic	et	al.,	
2000,	Ryan	et	al.,	2006)		
HADS*(Ndosi	et	al.,	2014)	
		
Self-efficacy	 NHP*	(Maravic	et	al.,	2000,	Primdahl	et	al.,	2014)	
Patient	attitude/	
perception	of	
ability	to	control	
arthritis	
SF-12*	(MCS)	(Primdahl	et	al.,	2014)	
ASES-	DK*	(Ndosi	et	al.,	2014,	Primdahl	et	al.,	2014)	
RASEQ*	(Primdahl	et	al.,	2014)	
RAI*	(Ryan	et	al.,	2006)	
	
RAID*	(Dougados	et	al.,	2015)	
		 Quality	of	life	 Quality	of	Life	 NHP*	(Maravic	et	al.,	2000,	Primdahl	et	al.,	2014)	 		
RAQoL*	(Ndosi	et	al.,	2014,	Tijhuis	et	al.,	2003)	
RAND-36*	(Tijhuis	et	al.,	2003)	
RAID*	(Dougados	et	al.,	2015)	
SF-12*	(Primdahl	et	al.,	2014)	
Resource	Use/	
Economic	Impact	
Costs	 Health	utility	 EQ5D*	(Ndosi	et	al.,	2014,	Watts	et	al.,	2015)	
	
Record	of	health	care	
resource	data	(Ndosi	et	
al.,	2014)	
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Healthcare	
resources	
Health	Utility	Rating	Scale*	(Ndosi	et	al.,	2014)	 Number	of	
hospitalisations	(Tijhuis	
et	al.,	2003)	
		 	 	 Use	of	home	help	
(Tijhuis	et	al.,	2003)Drug	
use	(Tijhuis	et	al.,	2003)	
		 	 	 Consultations	with	
other	health	care	
professionals	(Ryan	et	
al.,	2006,	Tijhuis	et	al.,	
2003)	
		 	 	 Changes	in	RA	DMARD	
therapy	(Dougados	et	
al.,	2015)	
		 		 		 Measures	taken	against	
comorbidities	
(Dougados	et	al.,	2015)	
Death	 Death	 Death**	 		 Death	(Primdahl	et	al.,	
2014)	
**	Reporting	mortality	is	a	regulatory	requirement	for	all	clinical	studies.	
Table	4	legend	
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*Index	paper	reference	provided	by	author	
Abbreviations	in	alphabetical	order	:	AIMS:	Arthritis	Impact	Measurement	Scale,	ASES,	Arthritis	Self-Efficacy	Scale,	CNS:	clinical	nurse	specialist	
CRP:	C-reactive	protein,DAS28:	Disease	Activity	Score	28	joints,	EMS:	early	morning	stiffness	duration,	EQ5D:	EuroQoL,	ESR:	erythrocyte	
sedimentation	rate,		HADs:	Hospital	anxiety	and	depression	scale,	HAQ-DI:	health	assessment	questionnaire	disability	index,	LSQ,	Leeds	
Satisfaction	Questionnaire,	MACTAR:	McMaster	Toronto	Arthritis	Patient	Preference	Disability	Questionnaire,	MCS:	Mental	health	composite	
score,	MHAQ	Modified	Health	Assessment	Questionnaire,	NHP:	Nottingham	Health	Profile,	PCS:	Physical	health	composite	score,	PKQ:	Patient	
Knowledge	Questionnaire,	RADAI	:Rheumatoid	arthritis	disease	activity	index,	RAI:	Rheumatology	Attitude	Index,	RAID	Rheumatoid	Arthritis	
Impact	of	Disease	RAND:	RAND	36-item	Health	Survey,	RAQoL:	Rheumatoid	Arthritis	Quality	of	Life	Scale,	RASEQ:	Rheumatoid	arthritis	self-
efficacy	questionnaire,	SF-12;	short-form	12;	SJW:	swollen	joint	count,	TJC:	Tender	joint	count,	VAS:	visual	analogue	scale.		
	
	
